Results 21 to 30 of about 72,883 (309)
An Updated Review on Current Treatment of Alopecia Areata and Newer Therapeutic Options
International Journal of Trichology, 2023 Alopecia areata (AA) is a dermatological disease that causes nonscarring hair loss. It can occur at any age and has an unpredictable and variable evolution in individuals.
K. Malhotra, Bhushan Madke
semanticscholar +1 more source
Alopecia Areata: Burden of Disease, Approach to Treatment, and Current Unmet Needs
Clinical, Cosmetic and Investigational Dermatology, 2023 Alopecia areata is an autoimmune hair loss disorder with variations in distribution, duration, and severity. The disease is chronic and often follows an unpredictable course, frequently leading to stress and anxiety for those who suffer from it ...
Lina Alhanshali +3 more
semanticscholar +1 more source
Two Phase 3 Trials of Baricitinib for Alopecia Areata.
New England Journal of Medicine, 2022 BACKGROUND Alopecia areata is an autoimmune condition characterized by rapid hair loss in the scalp, eyebrows, and eyelashes, for which treatments are limited.
B. King +15 more
semanticscholar +1 more source
An overview of JAK/STAT pathways and JAK inhibition in alopecia areata
Frontiers in Immunology, 2022 Alopecia Areata (AA) is a common autoimmune disease characterized by non-scarring hair loss ranging from patches on the scalp to complete hair loss involving the entire body. Disease onset is hypothesized to follow the collapse of immune privilege of the
M. Lensing, A. Jabbari
semanticscholar +1 more source
Alopecia Areata Occurring after COVID-19 Vaccination: A Single-Center, Cross-Sectional Study
Vaccines, 2022 Limited data concerning the development of autoimmune skin diseases after COVID-19 vaccination are currently available. Recently, a few reports described the development, worsening or recurrence of alopecia areata after the administration of COVID-19 ...
Francesco Tassone +5 more
doaj +1 more source
Alopecia areata – Current understanding and management
Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG, 2022 Alopecia areata (AA) is a chronic, immune‐mediated disease characterized by acute or chronic non‐scarring hair loss, with a heterogeneity in clinical manifestations ranging from patchy hair loss to complete scalp and body hair loss. An overview of the up‐
D. Lintzeri +5 more
semanticscholar +1 more source
Lifestyle Factors Involved in the Pathogenesis of Alopecia Areata
International Journal of Molecular Sciences, 2022 Alopecia areata is a representative inflammatory skin disease that is associated with various environmental stimuli. While psychological stress is believed to be a major pathogenetic trigger in alopecia areata, infants and newborns also suffer from the ...
Yoko Minokawa +2 more
semanticscholar +1 more source
British Journal of Dermatology, 2022 Alopecia areata (AA) is a common cause of nonscarring hair loss that can have a profound psychological impact.
A. Macbeth +7 more
semanticscholar +1 more source
Evaluating the Therapeutic Potential of Ritlecitinib for the Treatment of Alopecia Areata
Drug Design, Development and Therapy, 2022 Alopecia areata (AA) is an autoimmune condition that causes patchy hair loss, affecting up to 147 million people globally. Currently, there are no treatments approved by US Food and Drug Administration (FDA) specific for AA, and there are few effective ...
H. Ramírez-Marín, A. Tosti
semanticscholar +1 more source
Scalp biomarkers during dupilumab treatment support Th2 pathway pathogenicity in alopecia areata
Allergy. European Journal of Allergy and Clinical Immunology, 2022 The mechanisms driving alopecia areata (AA) are still unclear, hindering development of targeted therapeutics. Specific Th2 targeting with dupilumab in AA provides a unique opportunity to dissect its pathogenesis and explore the role of Th2 pathway.
Y. Renert-Yuval +14 more
semanticscholar +1 more source